Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Neuropharmacology | journal | 0.799 Q2 | 103 | 35 | 170 | 4661 | 494 | 162 | 2.30 | 133.17 | |
2 | Recent Patents on CNS Drug Discovery | journal | 0.803 Q2 | 36 | 25 | 58 | 3322 | 179 | 58 | 3.03 | 132.88 | |
3 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.082 Q1 | 52 | 24 | 80 | 3030 | 254 | 77 | 2.98 | 126.25 | |
4 | Current Medicinal Chemistry | journal | 1.538 Q1 | 202 | 504 | 1001 | 59089 | 5168 | 970 | 4.57 | 117.24 | |
5 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 22 | 79 | 2504 | 141 | 79 | 1.46 | 113.82 | ||
6 | Current Gene Therapy | journal | 1.565 Q1 | 80 | 45 | 141 | 5121 | 693 | 127 | 5.30 | 113.80 | |
7 | Current Pharmaceutical Design | journal | 1.280 Q1 | 183 | 585 | 1163 | 65504 | 4819 | 1058 | 3.77 | 111.97 | |
8 | Current Protein and Peptide Science | journal | 1.339 Q1 | 96 | 74 | 204 | 8257 | 600 | 179 | 2.23 | 111.58 | |
9 | Current Cancer Drug Targets | journal | 1.789 Q1 | 103 | 89 | 255 | 9901 | 1288 | 238 | 4.31 | 111.25 | |
10 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 22 | 55 | 2367 | 179 | 54 | 2.50 | 107.59 | ||
11 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.837 Q3 | 39 | 31 | 100 | 3330 | 273 | 91 | 2.09 | 107.42 | |
12 | Current Diabetes Reviews | journal | 1.034 Q2 | 68 | 49 | 129 | 5136 | 460 | 127 | 3.24 | 104.82 | |
13 | Current Organic Synthesis | journal | 1.102 Q2 | 55 | 53 | 110 | 5470 | 284 | 101 | 1.94 | 103.21 | |
14 | Current Molecular Pharmacology | journal | 1.560 Q1 | 49 | 39 | 59 | 3998 | 291 | 57 | 4.38 | 102.51 | |
15 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.179 Q3 | 28 | 25 | 75 | 2498 | 56 | 74 | 0.94 | 99.92 | |
16 | Current Signal Transduction Therapy | journal | 0.246 Q3 | 22 | 34 | 95 | 3349 | 59 | 88 | 0.49 | 98.50 | |
17 | Current Drug Targets | journal | 1.332 Q1 | 119 | 194 | 483 | 18772 | 1881 | 438 | 4.21 | 96.76 | |
18 | Open Ecology Journal | journal | 1.845 Q1 | 18 | 6 | 32 | 579 | 130 | 32 | 3.63 | 96.50 | |
19 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.502 Q2 | 43 | 34 | 78 | 3271 | 168 | 78 | 1.96 | 96.21 | |
20 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.027 Q2 | 108 | 121 | 293 | 11637 | 971 | 261 | 3.00 | 96.17 | |
21 | Current Topics in Medicinal Chemistry | journal | 1.409 Q1 | 133 | 233 | 510 | 22139 | 1975 | 440 | 3.77 | 95.02 | |
22 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.819 Q2 | 63 | 40 | 101 | 3682 | 226 | 97 | 1.69 | 92.05 | |
23 | Current Women's Health Reviews | journal | 0.199 Q3 | 16 | 36 | 133 | 3270 | 52 | 118 | 0.45 | 90.83 | |
24 | Current Enzyme Inhibition | journal | 0.221 Q3 | 19 | 12 | 68 | 1077 | 49 | 65 | 0.65 | 89.75 | |
25 | Current Organic Chemistry | journal | 1.406 Q1 | 112 | 193 | 491 | 17062 | 1536 | 448 | 2.98 | 88.40 | |
26 | Mini-Reviews in Medicinal Chemistry | journal | 0.941 Q1 | 107 | 140 | 364 | 12246 | 1255 | 356 | 3.41 | 87.47 | |
27 | Current Chemical Biology | journal | 0.378 Q2 | 26 | 27 | 80 | 2346 | 141 | 77 | 0.63 | 86.89 | |
28 | Current Genomics | journal | 1.273 Q2 | 77 | 67 | 184 | 5787 | 595 | 175 | 3.01 | 86.37 | |
29 | Current Proteomics | journal | 0.296 Q3 | 27 | 24 | 90 | 2070 | 189 | 83 | 0.81 | 86.25 | |
30 | Current Angiogenesis | journal | 6 | 25 | 0 | 2145 | 0 | 0 | 0.00 | 85.80 | ||
31 | Recent Patents on Nanotechnology | journal | 0.504 Q1 | 36 | 24 | 57 | 2015 | 119 | 57 | 1.57 | 83.96 | |
32 | Current Immunology Reviews | journal | 0.332 Q3 | 23 | 36 | 128 | 3012 | 130 | 118 | 1.14 | 83.67 | |
33 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 27 | 65 | 2250 | 163 | 64 | 2.82 | 83.33 | ||
34 | Current Alzheimer Research | journal | 1.509 Q1 | 103 | 120 | 254 | 9914 | 1139 | 241 | 3.98 | 82.62 | |
35 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.235 Q3 | 17 | 34 | 78 | 2748 | 37 | 70 | 0.39 | 80.82 | |
36 | Current Rheumatology Reviews | journal | 0.197 Q3 | 29 | 38 | 129 | 3036 | 61 | 106 | 0.35 | 79.89 | |
37 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 34 | 98 | 2712 | 252 | 95 | 2.60 | 79.76 | ||
38 | Recent Patents on Biotechnology | journal | 0.547 Q2 | 42 | 23 | 59 | 1830 | 135 | 58 | 2.05 | 79.57 | |
39 | Recent patents on food, nutrition & agriculture | journal | 0.339 Q3 | 33 | 24 | 72 | 1867 | 120 | 72 | 1.33 | 77.79 | |
40 | Infectious Disorders - Drug Targets | journal | 0.593 Q2 | 61 | 47 | 145 | 3616 | 275 | 129 | 1.89 | 76.94 | |
41 | Current Drug Discovery Technologies | journal | 0.801 Q2 | 49 | 34 | 94 | 2615 | 288 | 87 | 2.45 | 76.91 | |
42 | Current Hypertension Reviews | journal | 0.211 Q3 | 27 | 39 | 105 | 2954 | 48 | 100 | 0.47 | 75.74 | |
43 | Current Vascular Pharmacology | journal | 0.975 Q1 | 69 | 107 | 217 | 8016 | 744 | 205 | 3.15 | 74.92 | |
44 | Current Stem Cell Research and Therapy | journal | 1.065 Q1 | 63 | 49 | 120 | 3616 | 471 | 114 | 3.33 | 73.80 | |
45 | CNS and Neurological Disorders - Drug Targets | journal | 1.492 Q1 | 96 | 123 | 237 | 9055 | 913 | 208 | 3.68 | 73.62 | |
46 | Current Bioinformatics | journal | 0.238 Q4 | 38 | 53 | 87 | 3834 | 180 | 84 | 2.19 | 72.34 | |
47 | Current Medical Imaging | journal | 0.261 Q3 | 37 | 37 | 113 | 2613 | 73 | 101 | 0.57 | 70.62 | |
48 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.183 Q3 | 27 | 35 | 109 | 2441 | 66 | 98 | 0.47 | 69.74 | |
49 | Current Cancer Therapy Reviews | journal | 0.226 Q3 | 17 | 39 | 94 | 2649 | 57 | 93 | 0.56 | 67.92 | |
50 | Mini-Reviews in Organic Chemistry | journal | 0.635 Q2 | 43 | 41 | 120 | 2782 | 225 | 114 | 1.11 | 67.85 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®